VivePeptides logo

Research Use Only

Peptides for Energy

Peptides investigated in the context of mitochondrial biogenesis, NAD+ metabolism, and cellular bioenergetics.

Peptides for Energy are research compounds studied for their roles in cellular bioenergetics, mitochondrial function, and metabolic signaling pathways. This category includes NAD+ (a coenzyme examined in sirtuin and redox signaling research), MOTS-c (a mitochondria-derived peptide investigated for AMPK pathway activation), and SS-31 (a mitochondria-targeting tetrapeptide studied for cardiolipin interaction). All compounds are for preclinical research use only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

NAD+ research peptide vial

NAD+

$80.00View
MOTS-c research peptide vial

MOTS-c

$75.00View
SS-31 research peptide vial

SS-31

$85.00View

Research Overview

Energy Peptides: A Research Category Built Around Mitochondrial and Metabolic Mechanisms

The peptides for energy research category encompasses compounds investigated for their interactions with cellular energy-generation systems, particularly mitochondrial function, metabolic enzyme pathways, and NAD-dependent signaling cascades. Identifying the best peptides for energy pathway research depends on matching mechanism class to the specific target under investigation, as distinct molecular targets require distinct tool compounds. Three mechanism classes are represented in this collection.

NAD+ is a coenzyme and central node in cellular redox chemistry, examined in models of sirtuin pathway activation and PARP-mediated signaling. MOTS-c is a mitochondria-derived peptide encoded in mitochondrial DNA, investigated for its role in AMPK activation and glucose metabolism regulation. SS-31 is a mitochondria-targeting tetrapeptide studied for its interaction with cardiolipin within the inner mitochondrial membrane.

VivePeptides supplies each compound with documented purity specifications and certificates of analysis, supporting reproducible laboratory research.

Three Distinct Mitochondrial Mechanisms

NAD+, MOTS-c, and SS-31 each engage a different point in the bioenergetic cascade, from upstream redox enzyme activity to mitochondria-encoded peptide signaling to direct inner membrane cardiolipin interaction. Researchers can target upstream, midstream, or membrane-level nodes depending on their model.

Analytical Documentation for Every Compound

Each energy peptide in this collection is supplied with a certificate of analysis confirming purity by HPLC and mass spectrometry identity, meeting the documentation standards expected in preclinical publication. Verified purity reduces the risk of confounding variables in mechanistic assays.

Matching Compound to Research Target

Selecting among energy peptides requires clarity about the pathway compartment under study: sirtuin and PARP signaling models call for NAD+, AMPK-mediated metabolic studies call for MOTS-c, and cardiolipin-dependent bioenergetic research calls for SS-31. No single compound covers all three axes.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
NAD+Coenzyme, sirtuin and PARP substrateRedox signaling, NAD+/NADH modulationUpstream regulator of multiple enzyme classes
MOTS-cMitochondria-derived peptideAMPK activation, glucose metabolismEncoded within mitochondrial DNA
SS-31Mitochondria-targeting tetrapeptideCardiolipin interaction, electron transport chainInner mitochondrial membrane specificity

Mechanism & Research Context

Mechanism Classes and Preclinical Research Context for Energy-Related Peptide Studies

What distinguishes the energy peptides in this collection is the specificity of their mechanistic targets within the mitochondrial and metabolic signaling architecture. NAD+ operates upstream of multiple regulatory enzymes as a substrate for sirtuins and PARPs. Preclinical literature has examined how cellular NAD+/NADH ratios influence sirtuin activity and downstream transcriptional programs related to metabolic regulation.

MOTS-c acts through a distinct intracellular signaling axis, with research models investigating its capacity to activate AMPK and modulate insulin-independent glucose utilization. SS-31 targets the inner mitochondrial membrane directly, with studies examining cardiolipin stabilization and electron transport chain efficiency under conditions of oxidative stress. Researchers selecting among these compounds typically do so based on target pathway: upstream redox enzyme signaling, mitochondria-derived peptide signaling, or membrane-level bioenergetic modulation.

Each compound presents different solubility profiles and reconstitution requirements that should be factored into study design.

Research FAQ

Frequently asked questions

What are peptides for energy in a research context?

Peptides for energy are research compounds investigated for their roles in mitochondrial function, cellular redox signaling, and metabolic enzyme pathway modulation. This category includes coenzymes such as NAD+, mitochondria-derived peptides such as MOTS-c, and mitochondria-targeting peptides such as SS-31, each acting at distinct points in the bioenergetic cascade. All compounds in this category are supplied for in vitro and preclinical laboratory research use only, with no intended application in humans or animals outside of controlled study settings.

What is the difference between NAD+, MOTS-c, and SS-31?

NAD+, MOTS-c, and SS-31 represent three distinct mechanism classes within energy-related preclinical research. NAD+ is a coenzyme that serves as a substrate for sirtuin and PARP enzymes involved in redox-dependent metabolic regulation, while MOTS-c is a mitochondria-derived peptide investigated for AMPK pathway activation and insulin-independent glucose utilization. SS-31 is a synthetic tetrapeptide studied for its selective interaction with cardiolipin at the inner mitochondrial membrane, which positions it in a structurally and functionally distinct research space from the other two compounds.

How do researchers select the best peptides for energy pathway studies?

Researchers select the best peptides for energy studies by identifying which node of the bioenergetic pathway their model is designed to interrogate. Studies targeting upstream redox enzyme signaling typically use NAD+ as the tool compound, while those focused on AMPK-mediated metabolic regulation examine MOTS-c. When the research question concerns inner mitochondrial membrane biophysics and electron transport chain function, SS-31 is the appropriate selection based on its cardiolipin-targeting mechanism.

What is MOTS-c and why is it studied in energy research?

MOTS-c is a mitochondria-derived peptide encoded within the 12S rRNA region of mitochondrial DNA, making it mechanistically distinct from nuclear-encoded peptides investigated in metabolic research. Preclinical literature has examined its role in activating the AMPK signaling pathway and modulating glucose uptake in cellular and animal models. Its origin within the mitochondrial genome gives it a unique position in the study of retrograde mitochondria-to-nucleus signaling, distinguishing it from other compounds in the energy peptides category.

What does preclinical research examine about SS-31?

SS-31 is a synthetic tetrapeptide studied in preclinical research for its selective accumulation at the inner mitochondrial membrane via electrostatic interaction with cardiolipin, a phospholipid critical to electron transport chain complex organization. Research models have examined how this interaction influences mitochondrial membrane potential and ATP synthesis rates under conditions of oxidative stress. SS-31 is used as a tool compound for investigating the biophysical consequences of cardiolipin remodeling in models relevant to mitochondrial dysfunction.

What purity and quality standards should researchers require when sourcing energy peptides?

Researchers sourcing energy peptides for preclinical studies should require a certificate of analysis confirming purity by HPLC, alongside mass spectrometry data confirming molecular identity. Purity at or above 98 percent is generally appropriate for mechanistic cell-based assays, as lower purity batches may introduce confounding impurities that complicate interpretation of pathway-level results. VivePeptides provides full analytical documentation for each compound in this collection, enabling researchers to assess lot-to-lot consistency across experimental runs.

Related Research Collections

Continue exploring

Longevity PeptidesPeptides for Weight LossGLP-1 PeptidesPeptides for Fat Burning

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.